Compare Neurocrine Biosciences Inc (NBIX) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Unilever plc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Unilever plc is far larger — about 7.6× Neurocrine Biosciences Inc's market cap, and Unilever plc pays a 3.68% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | UL | |
|---|---|---|
Market Cap | $17.40B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $180.55 | $74.59 |
52-Week Low | $123.10 | $55.05 |
Enterprise Value | $16.49B | $157.31B |
Dividend Yield | — | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
